Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
2,534,263
-
Total 13F shares
-
27,563,193
-
Share change
-
+27,563,193
-
Total reported value
-
$757,434,770
-
Price per share
-
$27.48
-
Number of holders
-
52
-
Value change
-
+$757,435,025
-
Number of buys
-
52
Institutional Holders of Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) as of Q2 2021
As of 30 Jun 2021,
Singular Genomics Systems, Inc. - Common Stock, $0.0001 par value (OMIC) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,563,193 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), PERCEPTIVE ADVISORS LLC, Casdin Capital, LLC, FMR LLC, COATUE MANAGEMENT LLC, ORBIMED ADVISORS LLC, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, Alphabet Inc., and Nicholas Investment Partners, LP.
This page lists
52
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.